33 results
8-K12B
EX-3.4
SILO
SILO Pharma Inc
20 Dec 23
Notification of registration of securities
4:58pm
or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Corporation
8-K
EX-1.1
SILO
SILO Pharma Inc
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules … requirements of the Nasdaq Stock Market and, if applicable, at least one member of the Board of Directors must qualify as a “financial expert
424B4
aqhfocbw7gjlr6l
28 Sep 22
Prospectus supplement with pricing info
4:34pm
8-K
EX-10.1
li6m7sk fyf0qe07
12 Jul 21
Silo Pharma Enters into Sponsored Research Agreement with the University of Maryland, Baltimore
4:15pm
424B3
4pb6s2u
13 Apr 21
Prospectus supplement
6:02am
8-K
EX-10.1
w4s35l05 kb78xq4
7 Apr 21
Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology
4:15pm